Search results for "FDA update"


 
Results 11 - 20 of about 100 for "FDA update".

SGLT2 inhibitors associated with ketoacidosis | ACP Diabetes Monthly

Sodium-glucose cotransporter-2 (SGLT2) inhibitors, including canagliflozin, dapagliflozin, and empagliflozin, may cause ketoacidosis, the FDA recently warned.

Alert on canagliflozin and amputations | ACP Diabetes Monthly

An ongoing clinical trial found an increase in leg and foot amputations, mostly affecting the toes, in patients treated with canagliflozin (Invokana, Invokamet), according to an FDA safety alert.

New long-acting insulin drugs approved | ACP Diabetes Monthly

Insulin degludec injection (Tresiba) and insulin degludec/insulin aspart injection (Ryzodeg 70/30) were approved by the FDA on Sept. 25.

FDA approves new treatment for diabetic foot ulcers | ACP Diabetes Monthly

The approval is an expanded indication for the device, which covers the ulcer and allows skin and tissue to regenerate and heal the wound.

Metformin solution recalled due to contamination | ACP Diabetes Monthly

Two lots of metformin hydrochloride oral solution (Riomet), 500 mg/5 mL, were recalled due to fungal contamination, the FDA said.

New warnings for fluoroquinolones about risk of hypoglycemic coma | ACP Diabetes Monthly

The labeling changes for fluoroquinolones will also make the mental health side effects more prominent and more consistent across the drug class.

New indication approved for empagliflozin | ACP Diabetes Monthly

Empagliflozin (Jardiance) is approved for a new indication—to reduce the risk of cardiovascular death in adults with type 2 diabetes and cardiovascular disease.

Insulin needles failing to deploy | ACP Diabetes Monthly

Several lots of the OmniPod Insulin Management System were affected by a recent field safety notification about needle mechanisms failing to deploy or demonstrating a delay in deployment.

Combo of metformin and dapagliflozin approved | ACP Diabetes Monthly

A once-daily combination pill of dapagliflozin and metformin HCl extended-release (Xigduo XR) was recently approved by the FDA.

Glucose monitoring system approved specifically for critical care units | ACP Diabetes Monthly

The FDA recently approved a new indication for the Nova StatStrip Glucose Hospital Meter System, extending its use to critically ill patients who have been hospitalized.

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next